Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
5
Number of overlapping holdings
20.8%
% of PPH's 27 holdings also in OZEM
20.8%
% of OZEM's 25 holdings also in PPH
Overlap by Weight
Sector Drift (PPH minus OZEM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.9% | 17.7% | 11.9% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.9% | 5.2% | 4.9% |
 |
NOVO-NORDISK A/S-SPONS ADR | 4.7% | 12.7% | 4.7% |
|
PFIZER INC | 4.4% | 3.7% | 3.7% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONSORED ADR | 4.6% | 2.4% | 2.4% |
Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to OZEM
|
JOHNSON & JOHNSON | 6.6% |
|
ABBVIE INC | 6.5% |
 |
NOVARTIS AG-ADR | 5.2% |
|
CENCORA INC | 4.9% |
 |
SANOFI-AVENTIS-ADR | 4.9% |
|
MERCK & CO. INC. | 4.8% |
|
MCKESSON CORP | 4.7% |
|
ZOETIS INC | 4.6% |
|
BRISTOL-MYERS SQUIBB CO | 4.5% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 4.5% |
PPH Underweight Relative to OZEM
|
NOVO-NORDISK A/S-SPONS ADR | -8.0% |
|
ROCHE HOLDING LTD | -6.5% |
|
ELI LILLY & CO | -5.8% |
 |
INNOVENT BIOLOGICS, INC. | -4.9% |
|
CHUGAI PHARMACEUTICAL CO LTD | -4.8% |
|
AMGEN INC | -4.7% |
|
ZEALAND PHARMA A/S | -3.9% |
 |
HANMI PHARM CO LTD | -2.9% |
 |
THE UNITED LABORATORIES INTE | -2.7% |
|
GILEAD SCIENCES INC | -2.7% |